Therefore, given that the MGMT promoter methylation level can be used to predict the curative effects of TMZ (75), combining chemotherapy with drugs that target methylation changes may represent a promising new therapeutic approach for treating gliomas in the future. Here, MGMT is linked to central nervous system cancer.